Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BUDA
BUDA logo

BUDA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
10.000
Open
9.310
VWAP
9.75
Vol
60.03K
Mkt Cap
125.54M
Low
9.260
Amount
585.26K
EV/EBITDA(TTM)
--
Total Shares
12.57M
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).
Show More

Events Timeline

(ET)
2026-03-26
07:10:00
Buda Juice Reports FY25 Revenue of $12.6M
select
2026-01-22 (ET)
2026-01-22
07:10:00
Buda Juice IPO Completed with Additional 399,999 Shares Issued
select
2026-01-12 (ET)
2026-01-12
11:20:00
Aktis Oncology Shares Surge Over 5% on First Trading Day
select
2026-01-08 (ET)
2026-01-08
11:50:00
Buda Juice Prices IPO at $7.50 per Share
select
2026-01-07 (ET)
2026-01-07
17:30:00
MDB Capital Prices Deal at $7.50
select

News

seekingalpha
8.5
03-26seekingalpha
Buda Juice Reports Strong FY Results with $12.61M Revenue
  • Financial Highlights: Buda Juice, Inc. reported a FY GAAP EPS of $0.20 and revenue of $12.61 million, reflecting an 11.9% year-over-year growth, indicating strong performance and growth potential in the cold chain market.
  • Adjusted EBITDA: The company reported an adjusted EBITDA of $3.8 million, showcasing improved operational efficiency, which enhances investor confidence in its profitability.
  • Free Cash Flow: Buda Juice generated free cash flow of $3.0 million, demonstrating robust capital management that provides ample funding for future expansion and investments.
  • IPO Expectations: Buda Juice priced its initial public offering at $20 million, with positive market response, which is expected to further boost the company's market share and brand influence in the cold chain industry.
renaissancecapital
8.5
02-04renaissancecapital
2026 IPO Market Starts Steadily with $2.6 Billion Raised
  • IPO Market Performance: In January 2026, nine IPOs raised a total of $2.6 billion, although a backlog of startups indicated IPO plans, the overall deal count and proceeds fell below the ten-year average, reflecting cautious market sentiment.
  • Sector Dynamics: The industrial sector's EquipmentShare.com led with $747 million raised, surging 33% on its first day, indicating strong investor demand for fast-growing companies viewed as resistant to AI disruption.
  • SPAC Issuance Surge: January saw SPAC issuance reach a four-year high with 25 blank check deals raising $5.2 billion, providing hundreds of pre-IPO companies with an alternative path to public markets, reflecting growing interest in emerging technology firms.
  • Active IPO Pipeline: By the end of January, the IPO pipeline included 216 companies seeking to raise approximately $12.4 billion, with 130 having filed or updated within the last 90 days, demonstrating ongoing market interest in new public offerings.
renaissancecapital
8.5
02-04renaissancecapital
2026 IPO Market Starts Steadily with $2.6 Billion Raised
  • IPO Market Performance: In January 2026, nine IPOs raised a total of $2.6 billion, reflecting a cautious market sentiment as this figure fell short of the ten-year average, particularly after the volatility experienced in Q4 2025.
  • Sector Dynamics: The industrial sector led the month’s largest IPOs, with EquipmentShare.com raising $747 million, highlighting investor preference for fast-growing companies perceived as resilient to AI disruption.
  • Emerging Trends: The fintech and biotech sectors showed signs of recovery at the start of 2026, notably with fintech PicPay becoming the first Brazilian IPO in four years, raising $434 million, although its shares fell 5% post-IPO.
  • SPAC Activity: January saw SPAC issuance reach a four-year high with 25 deals raising $5.2 billion, indicating growing interest in pre-IPO companies opting for SPAC mergers, despite overall IPO activity remaining below 2021 peaks.
renaissancecapital
8.5
01-10renaissancecapital
Aktis Oncology Prices Upsized IPO at $318 Million, Targets Solid Tumors
  • Successful Financing: Aktis Oncology priced its upsized IPO at $318 million, achieving a market cap of $1 billion, marking the first significant deal of 2026 and demonstrating strong market interest in its radiopharmaceuticals targeting solid tumors.
  • Technological Edge: The company's alpha-emitting radiopharmaceuticals have shown superior efficacy in preclinical studies compared to Padcev, although it faces risks due to its early-stage pipeline, yet its unique treatment approach may attract investor attention.
  • Market Performance: Aktis saw a 24% increase in its stock price during its first week of trading, reflecting investor recognition of its potential market value and providing a solid foundation for future financing and R&D efforts.
  • Industry Outlook: With the rising demand for targeted therapies, Aktis's successful IPO not only enhances its visibility in the biotech sector but may also stimulate financing activities for similar companies, fostering growth across the industry.
Globenewswire
8.5
01-08Globenewswire
Buda Juice Begins Trading on NYSE American, Pioneering UltraFresh Juice Category
  • Listing Milestone: Buda Juice, Inc. commenced trading on the NYSE American on January 8, 2026, under the ticker symbol 'BUDA', marking its official entry into the fresh juice market and is expected to attract increased investor interest.
  • Innovative Product: The company offers UltraFresh™ juices through its cold chain platform, maintaining products at 35°F with an 8 to 12-day shelf life, significantly enhancing product quality for retailers and improving consumer experience.
  • Market Expansion: Buda Juice is expanding its branded portfolio, entering new geographic markets and scaling a growing white-label platform that provides significant cost savings and fresh product differentiation for retail customers, enhancing competitive positioning.
  • Strategic Advantage: By offering ready-to-drink juice solutions without the need for additional infrastructure, Buda Juice not only meets consumer demand for fresh beverages but also simplifies operational processes for retailers, thereby driving overall industry innovation.
renaissancecapital
8.5
01-08renaissancecapital
Buda Juice Raises $20 Million, Plans NYSE Listing Under BUDA
  • Successful Fundraising: Buda Juice raised $20 million by offering 2.7 million shares at $7.50 each, at the low end of the $7.50 to $9.00 range, providing essential funding for future growth despite market challenges.
  • Innovative Product Line: The company is pioneering the 'UltraFresh' juice category through its end-to-end cold chain platform, showcasing its innovative capabilities in the fresh citrus beverage market, which is expected to attract more retail customers and enhance market share.
  • Expansion Plans: Currently operating from its Dallas facility, Buda Juice plans to establish new facilities in South Carolina by 2026 and in Arizona/Nevada by 2027, indicating strong confidence in future growth and market expansion.
  • Listing Plans: The company intends to list on the NYSE American under the ticker BUDA, a move that will not only enhance brand visibility but also provide more opportunities for capital operations and market expansion.

Valuation Metrics

The current forward P/E ratio for Buda Juice Inc (BUDA.A) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess Buda Juice Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding BUDA

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Buda Juice Inc (BUDA) stock price today?

The current price of BUDA is 9.99 USD — it has decreased -0.1

What is Buda Juice Inc (BUDA)'s business?

Buda Juice, Inc. operates in a beverage industry, focused on UltraFresh juice-offering cold-crafted citrus-based drinks. The Company offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).

What is the price predicton of BUDA Stock?

Wall Street analysts forecast BUDA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BUDA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Buda Juice Inc (BUDA)'s revenue for the last quarter?

Buda Juice Inc revenue for the last quarter amounts to 3.17M USD, increased 9.06

What is Buda Juice Inc (BUDA)'s earnings per share (EPS) for the last quarter?

Buda Juice Inc. EPS for the last quarter amounts to 0.07 USD, decreased 0.00

How many employees does Buda Juice Inc (BUDA). have?

Buda Juice Inc (BUDA) has 0 emplpoyees as of March 31 2026.

What is Buda Juice Inc (BUDA) market cap?

Today BUDA has the market capitalization of 125.54M USD.